As a result of the ongoing collaboration between GEN İlaç and Galventa AG, a Distribution Agreement has been signed that regulates the distribution and launch of the first ever clinically tested Wake-Up capsules B・SYNC ON in Turkey and other markets. The signed agreement expects a minimum of 660,000 units to be sold between 2023 and 2025.
Within the framework of the agreement, GEN will be the sole and exclusive distributor for Turkey, Turkish Republic of Northern Cyprus, Serbia, Montenegro, Bosnia and Herzegovina, Macedonia, Kosovo, Moldova, Azerbaijan, Georgia, Ukraine, Uzbekistan, Thailand, Vietnam, Philippines, Russia, Belarus, Kazakhstan, Malaysia, Indonesia, Taiwan and Singapore.
Galventa AG is excited to see the product launch in markets outside of Europe and is looking forward to the collaboration with GEN İlaç.
